Navigation Links
Harvard's Wyss Institute develops technology to produce sugar from photosynthetic bacteria
Date:6/28/2010

Researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard and Harvard Medical School have engineered photosynthetic bacteria to produce simple sugars and lactic acid. This innovation could lead to new, environmentally friendly methods for producing commodity chemicals in bulk. Their research findings appear in the June issue of Applied and Environmental Microbiology.

This photosynthetic factory could also reduce the carbon dioxide emissions associated with transporting sugar globally from producing countries; lead to greater availability of biodegradable plastics; and allow capture of harmful CO2 emissions from power plants and industrial facilities.

In addition to its positive environmental impact, the technology offers potential economic advantages. Because the production methods use photosynthesis--the process by which living things are assembled using only CO2 and sunlight--the cost of making sugars, lactic acid, and other compounds would be significantly lower than traditional methods.

"What we're doing is using genetic engineering to get organisms to act the way we want them toin this case producing food additives," said Wyss Institute senior staff scientist Jeffrey Way, Ph.D. "These discoveries have significant practical implications in moving toward a green economy."

In addition to Dr. Way, researchers on this effort include Wyss Institute core faculty member Professor Pamela Silver, Ph.D., also of Harvard Medical School; and Henrike Niederholtmeyer, Bernd T. Wolfstadter, and David Savage, Ph.D., all of Harvard Medical School.

Sugar is primarily produced from sugar cane, which grows only in tropical and subtropical climates. By enabling production almost anywhere in the world, this living cellular manufacturing plant could greatly reduce the cost and emissions associated with transporting millions of tons of sugar to consumers every year.

It could also expand the
'/>"/>

Contact: Mary Tolikas
mary.tolikas@wyss.harvard.edu
Wyss Institute for Biologically Inspired Engineering at Harvard
Source:Eurekalert

Page: 1 2

Related biology news :

1. Left or right? Early clues to soccer penalty kicks revealed at Rensselaer Polytechnic Institute
2. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
3. Gladstone and Institute for Systems Biology collaborate on Huntingtons disease
4. National Eye Institute hosts Translational Research and Vision Symposium
5. University of Washington institute to get as much as $100 million to study atmosphere, ocean
6. Norwegian Institute of Public Health receives $100,000 Grand Challenges Explorations grant
7. La Jolla Institute scientist leads team which discovers important new player in diabetes onset
8. Harvards Wyss Institute uses natures design principles to create specialized nanofabrics
9. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
10. NOAA selects University of Miami to lead major southeastern US cooperative institute
11. Oklahoma Blood Institute to Leverage BIO-key(R) Breakthrough TruDonor(TM) Fingerprint Donor Identification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2014)... at the right time might actually help boost a ... help in understanding animal populations, pest control and managing ... the journal Trends in Ecology and Evolution , ... the kind of positive population effect an overall species ... on the size and developmental stage of the creatures ...
(Date:11/4/2014)... about the way our bodies are assembled during early ... they are supposed to become a nerve or a ... correct place and alignment? Researchers at the University of ... a new study, UM researchers describe the signaling systems ... at the head-trunk region. Their discovery may have important ...
(Date:11/4/2014)...   3D scanner ... Fuel3D , a developer of 3D scanning solutions, ... $6.4 million (£4 million). This funding builds on the company,s ... and paves the way for the commercial launch of the ... round was led by Chimera Partners and will be used ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2The inside story: How the brain and skull stay together 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3
... study from Rhode Island Hospital has found that a change ... contribute to improved outcomes of the victims and to the ... enforcement officers often serve as medical first responders, there is ... or should do, at the scene of an overdose. The ...
... MedNet Solutions , a global life sciences technology ... to announce that Accelovance , an award-winning, full-service ... Vaccines and General Medicine development, has joined the ... as an iMedNet Partner will facilitate Accelovance,s ...
... of Helsinki and Folkhlsan Research Center has identified a ... breeds, the Norwegian Elkhound and the Karelian Bear Dog. ... and a candidate gene for human chondrodysplasias. The finding ... health. A genetic test can now be used to ...
Cached Biology News:Changing laws, attitudes of police response to drug overdose may lead to better outcomes 2MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 2MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 3New dwarfism mutation identified in dogs 2
(Date:11/27/2014)... OXFORD, England , November 27, 2014 ... free online on ScienceDirect   Elsevier ... information products and solutions, is pleased to announce the ... Letters . The launch ... by the rapid advances at the forefront of applied ...
(Date:11/26/2014)... The report on the Global Smart ... concerned market for revenue forecasts and market trends. It ... 51.9% from 2013 to 2018. At the projected rate, ... $1,415.6 million by 2018. , Browse through the Global ... information about the market segmentation and in-depth analysis supported ...
(Date:11/26/2014)... 26, 2014 The announced sales of three ... is looking to expand in non-healthcare areas, says Kalorama ... market research firm says that  Siemens is the third ... survey of the IVD market , with 5.5 billion ... its composition would likely affect IVD market shares.  ...
(Date:11/26/2014)... The ETC (Emerging Technology Centers) http://www.etcbaltimore.com ... today that applications for AccelerateBaltimore™ (AB) 2015 program ... have a big idea?,” asked ETC’s President Deb ... it. AccelerateBaltimore helps you and your big idea ... weeks.” Interested game changers with “big ideas” ...
Breaking Biology Technology:Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 2Elsevier Announces the Launch of a New Journal: Extreme Mechanics Letters 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 2Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 4Kalorama: Sale of Three Siemens Healthcare Units Raises Questions About Firm's IVD Future 2AccelerateBaltimore Applications to Close in 6 Days 2AccelerateBaltimore Applications to Close in 6 Days 3
... Neuralstem, Inc. (NYSE Alternext US: CUR) announced ... present at the 11th Annual BIO CEO & ... 2009, at the Waldorf=Astoria Hotel, New York City.(Logo: ... February 9, 2009 at 10:00 a.m. Eastern Time.The ...
... Advances, Inc. (Cancer Advances), a Cato BioVentures portfolio company, ... all the technology and intellectual property for a suite ... in three gastrointestinal cancers. Cancer Advances was created as ... products developed to inhibit the hormone, gastrin, for an ...
... First proton pump inhibitor (PPI) with a ... OSAKA, Japan, Jan. 30 Takeda Pharmaceutical ... Pharmaceuticals North America, Inc., today announced that ... approved KAPIDEX(TM) (dexlansoprazole) delayed release capsules for ...
Cached Biology Technology:Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 3FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 2FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 3FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 4